XML 48 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of stock option activity
 
 
 
Year Ended
 
Year Ended
 
 
 
December 31, 2017
 
December 31, 2016
 
 
 
 
 
 
Wtd. Avg.
 
 
 
 
Wtd. Avg.
 
 
 
 
 
 
Exercise
 
 
 
 
Exercise
 
 
 
Shares
 
Price
 
Shares
 
Price
 
Outstanding at beginning of year
 
 
2,513,861
 
$
1.78
 
 
2,555,263
 
$
1.80
 
Granted
 
 
155,000
 
 
2.93
 
 
739,000
 
 
1.80
 
Exercised
 
 
(131,427)
 
 
1.17
 
 
(103,308)
 
 
1.22
 
Forfeited
 
 
(52,932)
 
 
3.45
 
 
(469,856)
 
 
2.15
 
Expired - vested
 
 
(94,490)
 
 
1.78
 
 
(207,238)
 
 
1.50
 
Outstanding at end of year
 
 
2,390,012
 
$
1.85
 
 
2,513,861
 
$
1.78
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock options exercisable at year end
 
 
1,583,585
 
$
1.72
 
 
1,329,392
 
$
1.66
 
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range
The following table summarizes information about service vesting-based stock options outstanding at December 31, 2017:
 
Range of
Exercise Prices
 
Number Outstanding at
December 31, 2017
 
Weighted Average
Remaining
Contractual Life
 
Weighted Average
Exercise Price
 
$
0.49-$1.00
 
 
17,855
 
 
1.17
 
$
0.60
 
$
1.01-$1.50
 
 
645,108
 
 
2.75
 
$
1.23
 
$
1.51-$2.50
 
 
1,632,408
 
 
7.56
 
$
1.93
 
$
2.51-$8.60
 
 
94,641
 
 
7.89
 
$
4.94
 
 
 
 
 
2,390,012
 
 
6.22
 
$
1.85
 
Weighted average assumptions of share based payment
The following is a summary of unvested restricted stock activity for 2017 and 2016, and the status of unvested restricted stock outstanding at December 31, 2017 and 2016:
 
 
 
Year Ended
 
Year Ended
 
 
 
December 31, 2017
 
December 31, 2016
 
 
 
 
 
 
Wtd. Avg.
 
 
 
 
Wtd. Avg.
 
 
 
 
 
 
Grant Date
 
 
 
 
Grant Date
 
 
 
Shares
 
Fair Value
 
Shares
 
Fair Value
 
Outstanding at beginning of year
 
 
98,439
 
$
1.90
 
 
––
 
$
––
 
Granted
 
 
207,350
 
 
1.76
 
 
200,000
 
 
1.90
 
Vested
 
 
(51,563)
 
 
1.90
 
 
(84,894)
 
 
1.90
 
Forfeited
 
 
(16,300)
 
 
1.76
 
 
(16,667)
 
 
1.90
 
Non-vested at end of year
 
 
237,926
 
$
1.79
 
 
98,439
 
$
1.90
 
Stock compensation expense
We recorded total stock compensation expense for the years ended December 31, 2017 and 2016, as follows:
 
 
 
Year Ended
December 31,
 
 
 
2017
 
2016
 
Research and development costs
 
$
236,972
 
$
151,849
 
Sales and marketing costs
 
 
230,461
 
 
176,878
 
General and administrative costs
 
 
638,346
 
 
426,035
 
Cost of product sales
 
 
164,424
 
 
2,794
 
Joint venture restructuring charges
 
 
––
 
 
19,438
 
Total
 
$
1,270,203
 
$
776,994